MoneyWorks4Me

The Revenue for the quarter ended  December 2025 of Rs. 25990.00 millions grew by 9.34 % from Rs. 23770.00 millions.A humble growth in net profit of 18.97% reported in the quarter ended December 2025 to Rs. 5770.00  millions from Rs. 4850.00 millions.OP of the company witnessed a marginal growth to 9920.00 millions from 8900.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 25990.00 23770.00 9.34 79770.00 72490.00 10.04 96820.00 85330.00 13.47
Other Income -80.00 30.00 -366.67 -400.00 170.00 -335.29 320.00 910.00 -64.84
PBIDT 9920.00 8900.00 11.46 30110.00 27240.00 10.54 36070.00 29810.00 21.00
Interest 340.00 480.00 -29.17 1160.00 1660.00 -30.12 2130.00 3030.00 -29.70
PBDT 9480.00 8420.00 12.59 28720.00 25580.00 12.28 33700.00 26780.00 25.84
Depreciation 1910.00 1910.00 0.00 5670.00 5700.00 -0.53 7600.00 7610.00 -0.13
PBT 7570.00 6510.00 16.28 23050.00 19880.00 15.95 26100.00 19170.00 36.15
TAX 1800.00 1660.00 8.43 5800.00 5740.00 1.05 7220.00 5600.00 28.93
Deferred Tax -500.00 410.00 -221.95 -680.00 1930.00 -135.23 1810.00 2380.00 -23.95
PAT 5770.00 4850.00 18.97 17250.00 14140.00 21.99 18880.00 13570.00 39.13
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 1692.30 0.00
PBIDTM(%) 38.17 37.44 1.94 37.75 37.58 0.45 37.25 34.93 6.64
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..